Cancer therapy-associated cardiotoxicity: A look at frailty

By sjmartinez • July 27, 2024

Hanlon E, Diaz ANR, Sedrak MS, Strom JB, Asnani A. Cancer therapy-associated cardiotoxicity: A look at frailty. J Geriatr Oncol. 2024 Jul 23:101835. doi: 10.1016/j.jgo.2024.101835. Epub ahead of print. PMID: 39048388.

Tags: anthracyclines, cardio-oncology, cardiotoxicity, Frailty, Geriatrics, heart failure, Hematology/Oncology, Publications

Identification of Targetable EGFR Mutations in Ovarian Cancer

Gower A, Win S, Ganguly R, Johnson M, Velez MA, Cummings AL, Lisberg A, Garon EB, Di Carlo B. Identification of Targetable EGFR Mutations in Ovarian Cancer.[...]

Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer

Chang K, Delavan HM, Yip E, Kasap C, Zhu J, Lodha R, Liao SY, Berman SC, Carretero-Gonzalez A, Basar M, Gokturk Ozcan G, Teo MY,[...]

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

Lawrenson K, Kar S, McCue K, Kuchenbaeker K, Michailidou K, Tyrer J, Beesley J, Ramus SJ, Li Q, Delgado MK, Lee JM, Aittomäki K, Andrulis[...]